The company had posted a net profit after tax, minority interest and share of profit of associates of Rs 169.43 crore for the corresponding period of the previous fiscal, Piramal Enterprises Ltd (PEL) said in a filing to BSE.
Total consolidated income from operations of the company also rose to Rs 1,776.22 crore for the quarter under consideration as against Rs 1,400.85 crore for the same period year ago.
PEL Chairman Ajay Piramal said: "The company again reported a robust revenue and profitability growth for Q1 FY 2017."
"We look forward to grow all our businesses both organically and through acquistions...," Piramal said.
During the quarter pharma solutions business's Mahad site cleared its first ever USFDA audit without any observation, the company said.
Shares of Piramal Enterprises today closed 1.20 per cent up at Rs 1,622.10 ascrip on BSE.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
